Deciphera Pharmaceuticals, Inc. Contracts & Agreements
66 Contracts & Agreements
- Business Finance (14 contracts)
- Business Operations (4)
- Human Resources (32)
- Intellectual Property (1)
- Mergers & Acquisitions (3)
- Real Estate (4)
- Uncategorized (8)
- Agreement and Plan of Merger, dated as of April 29, 2024, by and among Ono Pharmaceutical Co., Ltd., Topaz Merger Sub, Inc. and Deciphera Pharmaceuticals, Inc (Filed With SEC on April 29, 2024)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and (Filed With SEC on February 7, 2024)
- Compensation Recovery Policy (Filed With SEC on February 7, 2024)
- 2022 Inducement Plan, as amended (Filed With SEC on February 7, 2024)
- Consulting Agreement between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn, Ph.D., dated August 1, 2023 (Filed With SEC on October 30, 2023)
- Transition Agreement b (Filed With SEC on October 30, 2023)
- Open Market Sale Agreement (Filed With SEC on August 9, 2023)
- Form of Performance-Based Restricted Stock United Award Agreement for Non-U.S. Grantees under 2017 Stock Option and Inventive Plan (Filed With SEC on May 3, 2023)
- Form of Performance-Based Restricted Stock United Award Agreement for Company Employees under 2017 Stock Option and Inventive Plan (Filed With SEC on May 3, 2023)
- Deciphera Pharmaceuticals, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 7, 2023)
- 2022 Inducement Plan, as amended (Filed With SEC on February 7, 2023)
- Underwriting Agreement dated January 19, 2023 (Filed With SEC on January 20, 2023)
- Underwriting Agreement dated April 26, 2022 (Filed With SEC on April 28, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on April 28, 2022)
- Form of Restricted Stock Unit Award Agreement for Company Employees under 2022 Inducement Plan (Filed With SEC on February 8, 2022)
- Form of Non-Qualified Stock Option Agreement for Company Employees under 2022 Inducement Plan (Filed With SEC on February 8, 2022)
- 2022 Inducement Plan (Filed With SEC on February 8, 2022)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Stephen Ruddy (Filed With SEC on February 9, 2021)
- Form of Incentive Stock Option Agreement under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Non-Qualified Stock Option Agreement for Company Employees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Restricted Stock Unit Award Agreement for Company Employees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Non-Qualified Stock Option Agreement for Non-U.S. Optionees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Restricted Stock Unit Award Agreement for Non-U.S. Grantees under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Form of Non-Qualified Stock Option Agreement for Non-Employee Directors under 2017 Stock Option and Incentive Plan (Filed With SEC on February 9, 2021)
- Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on February 9, 2021)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn (Filed With SEC on February 9, 2021)
- Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel L. Flynn (Filed With SEC on February 9, 2021)
- Supply Agreement, made as of February 28, 2020, by and between Deciphera Pharmaceuticals, LLC and Cambrex (Filed With SEC on August 4, 2020)
- Commercial Manufacturing Services and Supply Agreement, made as of April 3, 2019, by and between Deciphera Pharmaceuticals, LLC and Lonza (Filed With SEC on August 4, 2020)
- Open Market Sale AgreementSM, dated August 4, 2020, by and between Deciphera Pharmaceuticals, Inc. and Jefferies LLC (Filed With SEC on August 4, 2020)
- Amendment No. 1 to Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on August 4, 2020)
- Letter Agreement, made as of January 17, 2020, by and between Deciphera Pharmaceuticals, LLC and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on May 5, 2020)
- Deciphera Pharmaceuticals, Inc (Filed With SEC on May 5, 2020)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Matthew L. Sherman (Filed With SEC on March 9, 2020)
- Description of Securities (Filed With SEC on March 9, 2020)
- Underwriting Agreement, dated February 13, 2020, by and among the Company, J.P. Morgan Securities LLC, Piper Sandler & Co. and Jefferies LLC (Filed With SEC on February 14, 2020)
- Deciphera Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on November 4, 2019)
- Underwriting Agreement, dated August 14, 2019, by and among the Company, J.P. Morgan Securities LLC, Piper Jaffray & Co. and Jefferies LLC (Filed With SEC on August 15, 2019)
- License Agreement, made as of June 10, 2019, by and between Deciphera Pharmaceuticals, LLC and Zai Lab (Shanghai) Co., Ltd (Filed With SEC on August 2, 2019)
- Third Amendment to Lease, dated April 29, 2019, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on May 3, 2019)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Daniel C. Martin (Filed With SEC on March 14, 2019)
- Amendment No. 1 dated October 26, 2018 to the Lease Agreement, dated May 29, 2018, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on March 14, 2019)
- Amendment No. 2 dated December 17, 2018 to the Lease Agreement, dated May 29, 2018, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on March 14, 2019)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Thomas P. Kelly (Filed With SEC on March 14, 2019)
- Transition Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, Inc., Deciphera Pharmaceuticals, LLC and Michael D. Taylor (Filed With SEC on March 4, 2019)
- Employment Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, LLC and Steven Hoerter (Filed With SEC on March 4, 2019)
- Employee Confidentiality, Assignment and Noncompetition Agreement, dated as of March 4, 2019, by and between Deciphera Pharmaceuticals, LLC and Steven Hoerter (Filed With SEC on March 4, 2019)
- Form of Underwriting Agreement (Filed With SEC on June 4, 2018)
- Lease Agreement, dated May 29, 2018, by and between Deciphera Pharmaceuticals, Inc. and 200 Smith NWALP Property Owner LLC (Filed With SEC on May 31, 2018)
- Reorganization Agreement and Plan of Merger by and among the Registrant, Deciphera Pharmaceuticals, LLC and the other parties named therein, dated October 2, 2017 (Filed With SEC on November 14, 2017)
- Registration Rights Agreement by and among the Registrant and certain of its stockholders, dated October 2, 2017 (Filed With SEC on November 14, 2017)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Michael D. Taylor, Ph.D. to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Oliver Rosen, M.D. to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Employment Agreement, between Deciphera Pharmaceuticals, LLC and Christopher J. Morl to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Form of Registration Rights Agreement among Deciphera Pharmaceuticals, Inc. and certain of its stockholders, to be in effect upon completion of this offering (Filed With SEC on September 25, 2017)
- Form of Reorganization Agreement and Plan of Merger among Deciphera Pharmaceuticals, Inc., Deciphera Pharmaceuticals LLC and the other parties named therein to be in effect... (Filed With SEC on September 25, 2017)
- Deciphera Pharmaceuticals, Inc. Senior Executive Cash Incentive Bonus Plan (Filed With SEC on September 22, 2017)
- Deciphera Pharmaceuticals, Inc. Non-Employee Director Compensation Policy (Filed With SEC on September 22, 2017)
- Form of Indemnification Agreement between Deciphera Pharmaceuticals, Inc. and each of its executive officers (Filed With SEC on September 22, 2017)
- Form of Indemnification Agreement between Deciphera Pharmaceuticals, Inc. and each of its directors (Filed With SEC on September 22, 2017)
- 2017 Employee Stock Purchase Plan (Filed With SEC on September 22, 2017)
- 2017 Stock Option and Incentive Plan and form of award agreements thereunder (Filed With SEC on September 22, 2017)
- Specimen Common Stock Certificate (Filed With SEC on September 22, 2017)
- Form of Underwriting Agreement (Filed With SEC on September 22, 2017)
- 2015 Equity Incentive Plan, as amended, and form of award agreements thereunder (Filed With SEC on September 18, 2017)
- Second Amended and Restated Investors Rights Agreement among Deciphera Pharmaceuticals, LLC and certain of its shareholders, dated May 26, 2017 (Filed With SEC on September 11, 2017)
